Today in Oncology
Failure to Adopt a Healthy Lifestyle More Than Doubles Risk of Metabolic S...7/28/2014 4:17:37 PM - The ASCO Post
First Surveillance Imaging at 6 Months May Be Adequate for Most Patients A...7/28/2014 3:40:22 PM - Susan Reckling
High Macrophage Inhibitory Cytokine-1 Levels and Colorectal Cancer RiskJuly 25, 2014, Volume 5, Issue 12 - Matthew Stenger
FDA Expands Approved Use of Ibrutinib for Chronic Lymphocytic Leukemia7/28/2014 3:31:15 PM - The ASCO Post
Phase II Trial Supports Use of First-Line Sunitinib vs Everolimus in Seque...7/28/2014 12:36:55 PM - Matthew Stenger
2014 Oncology MeetingsJuly 10, 2014, Volume 5, Issue 11 - The ASCO Post
Adding Induction Chemotherapy to Chemoradiotherapy Does Not Improve Surviv...7/28/2014 11:50:59 AM - Matthew Stenger
Statin Use Associated With Decreased Risk of Barrett's Esophagus7/24/2014 3:46:31 PM - The ASCO Post
Ipilimumab Reduces Recurrences as Adjuvant Treatment of MelanomaJuly 10, 2014, Volume 5, Issue 11 - Caroline Helwick
New Molecular Test Increases Odds of Correct Surgery for Thyroid Cancer Pa...7/24/2014 3:21:13 PM - The ASCO Post
Adaptive Intensity-Modulated Radiation Therapy Strategy May Ensure Adequat...7/24/2014 2:44:33 PM - Joseph Cupolo
Dutch Phase II Study Supports Phase III Evaluation of Bevacizumab Plus Lom...7/24/2014 12:58:11 PM - Matthew Stenger
AR-V7 Predicts Resistance to Enzalutamide and Abiraterone in Men With Cast...July 10, 2014, Volume 5, Issue 11 - Alice Goodman
Higher Plasma Vitamin D Concentration Associated With Reduced Cancer-Speci...7/24/2014 12:32:57 PM - Matthew Stenger
Antipain Agent Shrinks Oral Cancers, Sparing Healthy Tissue7/23/2014 3:52:24 PM - The ASCO Post
Yttrium-90 Radioembolization Improves Outcomes in Patients With Genotype 4...July 25, 2014, Volume 5, Issue 12 - Supplement - Jonathan Batchelor
Combined BRAF V600E and TERT Promoter Mutations Identify Aggressive and Re...7/23/2014 3:02:32 PM - Matthew Stenger
Study Defines Four Molecular Subtypes of Gastric Cancer7/23/2014 2:43:39 PM - Jo Cavallo
SIR Names James B. Spies, MD, MPH, FSIR, as President, 2014–2015July 25, 2014, Volume 5, Issue 12 - Supplement - Jonathan Batchelor
FDA Approves Idelalisib for Three Types of Blood Cancers7/23/2014 4:35:18 PM - The ASCO Post
Study Suggests That Primary Androgen-Deprivation Therapy Does Not Improve ...7/23/2014 12:24:51 PM - Matthew Stenger
Metabolic Enzyme Stops Growth of Most Common Type of Kidney Cancer7/22/2014 4:26:02 PM - The ASCO Post
Nonadherence With Maintenance Medication an Issue in Children With Leukemi...July 10, 2014, Volume 5, Issue 11 - The ASCO Post
Corticosteroids Improve Fatigue, Appetite Loss, and Patient Satisfaction b...7/22/2014 3:06:32 PM - Matthew Stenger
Depression Associated With Less Definitive Therapy and Poorer Survival in ...7/22/2014 12:35:25 PM - Matthew Stenger
Orphan Drug Designation Granted for New Agent in Hepatocellular CarcinomaJuly 25, 2014, Volume 5, Issue 12 - The ASCO Post
Anti–PD-1 Antibody Pembrolizumab Shows Activity and Good Tolerability in I...7/22/2014 12:13:14 PM - Matthew Stenger
FDA Grants Bevacizumab Priority Review for Recurrent Platinum-Resistant Ov...7/22/2014 10:47:36 AM - The ASCO Post
Bland vs Drug-Eluting Beads Show Similar Results for Embolization of Hepat...July 25, 2014, Volume 5, Issue 12 - Supplement - Jonathan Batchelor
No Disease-Free Survival Benefit of Adjuvant Zoledronic Acid in High-Risk ...7/21/2014 4:04:33 PM - Matthew Stenger
Noninvasive Image Texture Analysis May Provide Tumor Heterogeneity Informa...7/21/2014 3:45:38 PM - Susan Reckling
Negative HPV Screening Test Result Is a Better Predictor of Cervical Cance...7/21/2014 1:49:24 PM - The ASCO Post
IOM Workshop Explores Growing Problems in Patient Access to Cancer DrugsJuly 10, 2014, Volume 5, Issue 11 - Margot Fromer
Integrated Safety Analysis Shows Favorable Safety Profile of Single-Agent ...7/21/2014 1:42:04 PM - Matthew Stenger
Higher Marrow Levels of Plasmacytoid Dendritic Cells and Naive T Cells in ...7/21/2014 11:43:27 AM - Matthew Stenger
Siltuximab for Multicentric Castleman’s DiseaseJuly 10, 2014, Volume 5, Issue 11 - Matthew Stenger
Improved Survival in Hematologic Malignancies in Europe Between 1997 and 2...7/18/2014 3:05:48 PM - Matthew Stenger
Two Common Gene Variants Associated With Longer Telomere Length May Increa...7/18/2014 2:19:43 PM - Joseph Cupolo
Raja Flores, MD, Named Chair of New Thoracic Surgery Department at Mount S...July 10, 2014, Volume 5, Issue 11 - The ASCO Post
Minority of Older Patients With Low-Risk Prostate Cancer Managed by Observ...7/18/2014 12:42:57 PM - Matthew Stenger
Featured Columnists
Take-Home Messages From ASCO's Immediate Past President
Clifford A. Hudis, MD, FACP
The More Things Change, the More They Stay the Same
Jimmie C. Holland, MD, and James F. Holland, MD
Time to Move Forward With Lung Screening
James L. Mulshine, MD
Expert Opinions
The Road to Progress in Lung Cancer Treatment
ASCO Convenes Think Tank to Tackle Disparities in Cancer Care
Blase N. Polite, MD, MPP
Advancing Immune Checkpoint Targeting in Cancer Treatment
James P. Allison, PhD
Meeting News
Considerable Extension of Survival Achieved With Conventional Treatment in... Stakeholders Are Uniting Around Value in Cancer Care Multiple Myeloma Studies Explore Roles of Panobinostat in Relapsed/Refract... Neoadjuvant Chemotherapy Less Invasive Option for Advanced Ovarian Cancer,... More Meeting NewsJournal Spotlight
Sorafenib Improves Progression-Free Survival in Progressive Radioactive Io... Rilotumumab Added to First-Line Chemotherapy May Benefit Patients With Adv... Swiss Medical Board Members Discuss Recommendation to Phase Out Mammograph... HIV-Infected People With Early-Stage Cancers Are Up to Four Times More Lik... More Journal SpotlightsHealth-Care Policy
IOM Workshop Explores Growing Problems in Patient Access to Cancer Drugs ASCO Convenes Think Tank to Tackle Disparities in Cancer Care Cancer Care Under the Affordable Care Act Medicare Advisory Panel Cast Doubts on Lung Cancer Screening, Leaving Advocates Dismayed but Undaunted More Health-care PolicyDrugs & Regimens
Benefit Confirmed for Adjuvant Oxaliplatin in Rectal Cancer Impressive Delay in Thyroid Cancer Progression Achieved With Lenvatinib Considerable Extension of Survival Achieved With Conventional Treatment in Grade 2 Glioma Multiple Myeloma Studies Explore Roles of Panobinostat in Relapsed/Refractory Disease and Thalidomide Compared to Lenalidomide as Part of Initial Therapy More Drugs & RegimensOncology Worldwide
From Ireland to America and Back, Patrick G. Johnston, MD, PhD, Thrives on Bringing Research Findings to Clinical Practice Improving Quality of Life in Cancer Survivors A Vision of Independent Clinical Research in South America National Program to Screen Ashkenazi Women in Israel for BRCA Mutations Is Being Explored More Oncology Worldwide
Current Issue
July 25, 2014
Volume 5, Issue 12
View the
digital edition of
The ASCO Post
Supplement
Interventional Oncology and Its Role in the Management of Unresectable Hepatocellular Carcinoma
advertisement
CATEGORIES
Breast cancerProstate cancerAppointmentsLeukemiaLung cancerDirect from ASCOColorectal cancerLymphomaAwardsIntegrative careMultiple myelomaGastrointestinal cancerOtherMelanomaMolecular researchHead and Neck cancerTechnologyRenal cell cancerDrug safetyHealth-care policyPerspective More Categories
advertisement